一个扩展的贝叶斯半机械剂量检测设计用于I期瘤学试验,使用药理动力学和药理动力学信息
1Department of Biostatistics, Division of VP, Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Statistics in medicine
|December 18, 2023
概括
这项研究引入了一种用于瘤学试验的新型半机械剂量检测设计,整合了药理动力学/药理动力学 (PK/PD) 数据,以改善剂量毒性建模,并更准确地确定最大耐受剂量 (MTD).
科学领域:
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
- 生物统计学 生物统计学
背景情况:
- 第一阶段瘤学试验的目的是确定新疗法的最大耐受剂量 (MTD).
- 传统的剂量确定设计可能无法充分利用复杂的生物数据,如药理动力学/药理动力学 (PK/PD) 信息.
- 准确的MTD确定对于患者安全和随后的试验阶段至关重要.
研究的目的:
- 为I期瘤学试验提出和评估基于模型的半机械剂量检测 (SDF) 设计.
- 将药理动力学/药理动力学 (PK/PD) 生物标志物数据纳入剂量毒性关系建模中.
- 在早期癌症试验中提高MTD估计和患者分配的精度.
主要方法:
- 开发了PK,PD生物标志物和剂量限制毒性 (DLT) 结果的联合贝叶斯建模框架.
- 扩展了之前提出的SDF模型,包括相关的PD生物标志物测量.
- 进行了广泛的模拟研究,将拟议的设计与标准方法 (mTPI,BOIN,CRM) 和类似的SDF设计 (SDF-woPD) 进行比较.
主要成果:
- 与mTPI,BOIN,CRM和SDF-woPD相比,提出的SDF设计在选择正确的MTD和分配患者方面表现出卓越的性能.
- 当PK模型和链接函数被正确指定时,拟议的设计提供了比CRM和SDF-woPD更准确的剂量毒性曲线估计.
- 敏感性分析表明,该设计与先前的规格相比具有合理的稳定性,并可能对PK模型或链接函数进行错误规格.
结论:
- 拟议的PK/PD集成SDF设计为I期瘤学剂量检测研究提供了改进的方法.
- 这种方法提高了MTD识别的准确性,并优化了患者在早期癌症临床试验中的招生.
- 该设计的稳固性表明它在现实世界的临床试验环境中具有实际实用性.
更多相关视频
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
71
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
71
Nonlinear Pharmacokinetics: Overview
385
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
385
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
66
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
66
Pharmacokinetic Models: Overview
709
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
709


